Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the point-of-care molecular diagnostics market grown over the years?
The market size for point-of-care molecular diagnostics has seen a significant expansion in the past few years. Projections indicate that the market will increase from $3.55 billion in 2024 to $4.01 billion in 2025, representing a compound annual growth rate (CAGR) of 12.9%. Several factors contributed to this growth during the historical phase, including a surge in demand for quick disease diagnosis, a rise in incidences of infectious diseases, the development of telemedicine and remote testing, regulatory encouragement for point-of-care diagnostics, and a growing requirement for personalized and precise medicine.
What Is the forecasted market size and growth rate for the point-of-care molecular diagnostics market?
The market size for point-of-care molecular diagnostics is anticipated to experience swift expansion in the upcoming years, reaching $7.02 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%. Various factors contributing to the growth during this forecast period include the reduction in size of diagnostic devices, extended point-of-care testing for cancer and genetic disorders, personalised molecular diagnostics for a variety of applications, and the implementation of artificial intelligence and machine learning for data interpretation. Emerging infectious disease monitoring is also a significant factor. Noteworthy advancements expected in the forecast period encompass lab-on-a-chip and microfluidic technologies, digital health coupled with smartphone-based diagnostics, readiness for point-of-care COVID-19 and other potential pandemics, predictive diagnostics powered by AI, and CRISPR-based molecular examinations.
Get your point-of-care molecular diagnostics market report here!
What are the major factors driving growth in the point-of-care molecular diagnostics market?
The swift escalation in the prevalence of infectious and respiratory illnesses is projected to notably stimulate the progress of the point-of-care molecular diagnostics market. Respiratory infections, instigated by microorganisms such as viruses or bacteria that impact the respiratory system, can be transmitted by coughing, sneezing, or direct contact. The range of treatments for these severe respiratory ailments includes various inhalers, oral medications, intravenous therapies, and point-of-care molecular diagnostics to treat the patient. As reported by the Office for National Statistics, a reputable national statistics organization based in the UK, in England, as of the conclusion of the week ending December 9, 2022, the infection rate saw a rise in individuals aged 35 to 69 years and likewise surged for those in school years 12 to 24 years. Consequently, the swift rise in the incidence of infectious and respiratory diseases and related deaths will fuel the growth of the point-of-care molecular diagnostics market.
What key areas define the segmentation of the global point-of-care molecular diagnostics Market?
The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services
2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing
3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology
4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Subsegments:
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers
3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp
What are the top market players propelling the growth of the point-of-care molecular diagnostics industry?
Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.
What are the key trends shaping the future of the point-of-care molecular diagnostics market?
Technological advancement is a burgeoning trend in the point-of-care molecular diagnostics market. The primary players in the point-of-care molecular diagnostic market are intent on offering cutting-edge solutions to consolidate their market footprint. They are rolling out novel point-of-care molecular diagnostic technologies and associated services such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, among others, to POC devices, with an aim to expedite analysis times and reduce costs. For example, in May 2023, Sensible Diagnostics, a diagnostics company based in the US, introduced a 10-minute point-of-care PCR system. Sensible Diagnostics capitalizes on the expertise acquired by Curative through its diagnostics operation in the pandemic era. The company divulged that it has carried out more than two million molecular point-of-care COVID-19 tests, and its PCR platform delivers results in just 10 minutes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046
What regions are dominating the point-of-care molecular diagnostics market growth?
North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Point of Care Ultrasound Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-ultrasound-global-market-report
Veterinary Point Of Care Diagnostics Global Market Report 2024
Point of Care Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
